← back to search

Fei Ji

Novartis (Switzerland) · CH
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, RNA modifications and cancer, Cancer-related molecular mechanisms research, and Epigenetics and DNA Methylation.
h-index
40
citations
6,484
works
170
NIH funding
primary concept
email

Recent publications

snoRNA-facilitated protein secretion revealed by transcriptome-wide snoRNA target identification
Cell 2024cited by 47position: middledoi
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study
EClinicalMedicine 2023cited by 151position: middledoi
Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study
Clinical and Translational Medicine 2023cited by 51position: middledoi
An intranasal ASO therapeutic targeting SARS-CoV-2
Nature Communications 2022cited by 88position: middledoi
Regulation of chromatin accessibility by the histone chaperone CAF-1 sustains lineage fidelity
Nature Communications 2022cited by 34position: middledoi
Detection Interval Optimization for Diffusion-based Molecular Communication
ICC 2022 - IEEE International Conference on Communications 2022cited by 10position: middledoi
DEPCOD: a tool to detect and visualize co-evolution of protein domains
Nucleic Acids Research 2022cited by 3position: firstdoi
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in <scp>triple‐negative</scp>, <scp>early‐stage</scp> breast cancer (<scp>NeoCART</scp>): Results from a multicenter, randomized controlled, <scp>open‐label</scp> phase <scp>II</scp> trial
International Journal of Cancer 2021cited by 68position: middledoi
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation
Oncogene 2020cited by 434position: middledoi
Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database
Frontiers in Oncology 2020cited by 57position: middledoi
A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells
Genome biology 2020cited by 31position: middledoi
S-phase Enriched Non-coding RNAs Regulate Gene Expression and Cell Cycle Progression
Cell Reports 2020cited by 20position: middledoi
Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells
Nature Medicine 2019cited by 274position: middledoi
The RNA Helicase DDX6 Controls Cellular Plasticity by Modulating P-Body Homeostasis
Cell stem cell 2019cited by 156position: middledoi
Mitochondrial Dysfunction in C. elegans Activates Mitochondrial Relocalization and Nuclear Hormone Receptor-Dependent Detoxification Genes
Cell Metabolism 2019cited by 76position: middledoi
The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing
Molecular Cell 2019cited by 70position: middledoi
Polycomb Repressive Complex 1 Generates Discrete Compacted Domains that Change during Differentiation
Molecular Cell 2017cited by 345position: middledoi
The first case of ischemia-free organ transplantation in humans: A proof of concept
American Journal of Transplantation 2017cited by 157position: middledoi
Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling
Cell 2017cited by 157position: middledoi
IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
eLife 2017cited by 104position: middledoi
Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy
HPB 2017cited by 62position: firstdoi
PAR-TERRA directs homologous sex chromosome pairing
Nature Structural & Molecular Biology 2017cited by 57position: middledoi
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Nature Medicine 2016cited by 987position: middledoi
A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)
BMC Cancer 2016cited by 109position: firstdoi
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation
Oncotarget 2016cited by 25position: middledoi
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma
BMC Cancer 2015cited by 43position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ruslan I. Sadreyev · Harvard University11 papers (2017–2022)Yunpeng Hua · Sun Yat-sen University3 papers (2015–2017)Konrad Hochedlinger · Harvard University3 papers (2017–2022)Shaoqiang Li · State Key Laboratory of Respiratory Disease3 papers (2015–2017)Kun Wang · Jiangsu University3 papers (2020–2023)Shunjun Fu · Zhujiang Hospital3 papers (2015–2017)Liulu Zhang · King University3 papers (2020–2023)Baogang Peng · Bioscience Research3 papers (2015–2017) · 2 papers (2017–2019)Minyi Cheng · Southern Medical University2 papers (2021–2023)Teng Zhu · Guangdong University of Technology2 papers (2021–2023)Ciqiu Yang · Guangdong Academy of Medical Sciences2 papers (2020–2023)Justin Brumbaugh · Harvard University2 papers (2017–2019) · 2 papers (2019–2022)Hongfei Gao · Harbin Medical University2 papers (2020–2021)Bruno Di Stefano · Center for Cancer Research2 papers (2017–2019)Steven P. Gygi · Harvard University2 papers (2017–2019)Jieqing Li · Yunnan Agricultural University2 papers (2020–2021)Li‐Jian Liang · Sun Yat-sen University2 papers (2016–2017)Zhi‐Yong Wu · Sun Yat-sen University2 papers (2021–2023)